483
Views
46
CrossRef citations to date
0
Altmetric
MOUTH/PHARYNX

Effects and mechanism of OK-432 therapy in various neck cystic lesions

, , , &
Pages 1287-1292 | Received 13 Feb 2010, Accepted 25 Mar 2010, Published online: 07 May 2010

References

  • Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74:690–1.
  • Tsuchiya I, Kasahara T, Yamashita K, Ko YC, Kanazawa K, Matsushima K, Induction of inflammatory cytokines in the pleural effusion of cancer patients after the administration of an immunomodulator, OK-432: role of IL-8 for neutrophil infiltration. Cytokine 1993;5:595–603.
  • Kitsuki H, Katano M, Ikubo A, Morisaki T, Anann K, Tanaka M, Induction of inflammatory cytokines in effusion cavity by OK-432 injection therapy for patients with malignant effusion: role of interferon-γ in enhancement of surface expression of ICAM-1 on tumor cells in vivo. Clin Immunol Immunopathol 1996;78:283–90.
  • Ogita S, Tsuto T, Nakamura K, Deguchi E, Tokiwa K, Iwai N. OK-432 therapy for lymphangioma in children: Why and How does it work? J Pediatr Surg 1996;31:477–80.
  • Peters DA, Courtemanche DJ, Heran MK, Ludemann JP, Prendiville JS. Treatment of cystic lymphatic vascular malformations with OK-432 sclerotherapy. Plast Reconstr Surg 2006;118:1441–6.
  • Banieghal B, Davis MRQ. Guidelines for the successful treatment of lymphangioma with OK-432. Eur J Pediatr Surg 2003;13:103–7.
  • Ogita S, Tsuto T, Tokiwa K, Takahashi T. Intracystic injection of OK-432: a new sclerosing therapy for cystic hygroma in children. Br J Surg 1987;74:690–1.
  • Poldevaart MT, Breugem CC, Speleman L, Pasmans S. Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofacial Surg 2009;20:1159–62.
  • Kim MG, Kim SG, Lee JH, Eun YG, Yeo SG. The therapeutic effects on OK-432 (Picibanil) sclerotherapy for benign neck cysts. Laryngoscope 2008;118:2177–81.
  • Fukase S, Ohta N, Inamura K, Aoyagi M. Treatment of ranula with intracystic injection of the streptococcal preparation OK-432. Ann Otol Rhinol Laryngol 2003;112:214–20.
  • Roh JL, Sung MW, Kim KH, Park CI. Treatment of branchial cleft cyst with intracystic injection of OK-432. Acta Otolaryngol 2007;126:510–14.
  • Williams MA, Cave CM, Quaid G, Robinson C, Daly TJ, Witt D, Interleukin 8 dimerization as a mechanism for regulation of neutrophil adherence-dependent oxidant production. Shock 2005;23:371–6.
  • Fukase Y, Fukase S, Sendo F. Priming activity for chemiluminescence reaction of PMN in the culture supernatant of streptococcal preparation (OK-432)-stimulated spleen cells. Microbiol Immunol 1988;32:621–33.
  • Smedman C, Gardlund B, Nihlmark K, Gille-Johnson P, Andersson J, Paulie S. Elispot analysis of LPS-stimulated leukocytes: human granulocytes selectively secrete IL-8, MP-1 beta and TNF-alpha. J Immunol Methods 2009;346:1–8.
  • Monaghan-Benson, Burridge K. The regulation of vascular endothelial growth factor-induced microvascular permeability requires Rac and reactive oxygen species. J Biol Chem 2009;284:25602–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.